Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Dec 24 | PASG Passage Bio | Common stock, $0.0001 par value per share | Buy | Acquire P | Yes | No | 0.6451 | 373,645 | 241.04 k | 9,256,953 |
26 Dec 24 | TCRX TScan Therapeutics | Pre-funded Warrant Common Stock | Buy | Acquire P | Yes | No | 4 | 7,500,000 | 30.00 mm | 7,500,000 |
13 Dec 24 | TCRX TScan Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 2.9014 | 100,000 | 290.14 k | 5,357,347 |
12 Dec 24 | TCRX TScan Therapeutics | Common stock, $0.0001 par value per share ("Common Stock") | Buy | Acquire P | Yes | No | 3.0072 | 31,800 | 95.63 k | 5,257,347 |
27 Nov 24 | PASG Passage Bio | Common Stock | Buy | Acquire P | Yes | No | 0.6711 | 29,300 | 19.66 k | 8,883,308 |
26 Nov 24 | PASG Passage Bio | Common Stock | Buy | Acquire P | Yes | No | 0.7075 | 167,055 | 118.19 k | 8,854,008 |
25 Nov 24 | PASG Passage Bio | Common stock, $0.0001 par value per share ("Common Stock") | Buy | Acquire P | Yes | No | 0.5641 | 259,998 | 146.66 k | 8,686,953 |
15 Nov 24 | TCRX TScan Therapeutics | Common stock, $0.0001 par value per share | Buy | Acquire P | Yes | No | 4.3442 | 947 | 4.11 k | 5,225,547 |